Related Experiment Video
Updated: Jun 2, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Fungal endocarditis after transfemoral aortic valve implantation
Stuart J Head1, Todd M Dewey, Michael J Mack
1Cardiopulmonary Research Science and Technology Institute, Dallas, Texas, USA. s.head@erasmusmc.nl
Abstract:
Transcatheter aortic valve implantation (TAVI) was introduced in 2006 as an alternative for surgical aortic valve replacement (SAVR) as treatment for patients with aortic stenosis. Endocarditis after TAVI has been anecdotally reported, but concerns aroused because SAVR is often needed to explant the endocarditic valve in a high risk patient previously deemed not to be a surgical candidate. We report a case of a patient who underwent TAVI because he was too high risk to undergo SAVR. Several months later, he developed an intermittent self-limiting fever of unknown origin which eventually was diagnosed as endocarditis. The valve was surgically removed, and pathology showed an infection caused by Histoplasma capsulatum. The patient recovered fully and remains in good condition.
Insights
Transcatheter aortic valve implantation (TAVI) is an alternative for surgical aortic valve replacement. This case highlights a rare Histoplasma capsulatum infection after TAVI, requiring valve explantation and successful recovery.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Case Reports
Background:
- Transcatheter aortic valve implantation (TAVI) emerged as a less invasive alternative to surgical aortic valve replacement (SAVR) for aortic stenosis in 2006.
- Endocarditis post-TAVI is infrequently documented, raising concerns due to potential re-operation necessity in high-risk patients.
- This case addresses the management of endocarditis in a patient previously deemed inoperable for SAVR.
Observation:
- A patient, unsuitable for SAVR, underwent TAVI for severe aortic stenosis.
- Months post-TAVI, the patient presented with recurrent, self-limiting fevers of unknown origin.
- Diagnostic workup confirmed endocarditis affecting the implanted valve.
Findings:
- Infective endocarditis was diagnosed in a patient who had previously received TAVI.
- Surgical explantation of the TAVI valve was performed.
- Pathological analysis revealed the causative agent to be Histoplasma capsulatum.
Implications:
- This case underscores the possibility of rare fungal infections, such as Histoplasma capsulatum, following TAVI.
- It demonstrates the feasibility of surgical valve explantation and successful recovery in high-risk patients who have undergone TAVI.
- Highlights the importance of considering diverse etiologies for fever of unknown origin after TAVI.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Aortic Regurgitation I: Introduction
Aneurysm III: Interprofessional Care